InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Klein Lawrence Otto, 首席运营官. Insider active across 3 companies, notably CRISPR Therapeutics AG. Cumulatively, 10 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €6m. Activity tracked since 12 October 2022. The latest transaction was filed on 1 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Klein Lawrence Otto
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
75,000 股@ US$7.800.0097% mcap7.8% 占其流量Common StockSEC:0000907654-26-000087:0
6,604 股@ US$90.78680.0099% mcap7.9% 占其流量Common StockSEC:0000907654-26-000087:1
4,800 股@ US$92.43570.0074% mcap5.9% 占其流量Common StockSEC:0000907654-26-000087:3
63,596 股@ US$91.89630.097% mcap77.5% 占其流量Common StockSEC:0000907654-26-000087:2
1,729 股@ US$41.30100.0% 占其流量Common StockSEC:0000907654-26-000033:0
76,700 股0Common StockSEC:0000907654-26-000015:0
24,500 股0Voting Common StockSEC:0001213900-22-063947:0
4,584 股Common SharesSEC:0001209191-22-018611:0
26,667 股Common SharesSEC:0001209191-21-068455:0
10,000 股Common SharesSEC:0001209191-21-056092:0
10 条申报中的 10 条
About Klein Lawrence Otto
Klein Lawrence Otto is Chief Commercial Officer and Chief Operating Officer. He has 6 filings in total, and among the recent sampled filings, sales amount to EUR 62446 between 2021-09-14 and 2026-03-17, with the dominant transaction nature listed as option exercise.
